Skip to Main Content

Author Details

Dag Nyholm
Uppsala University
2001
108
30
PMIDPaper TitleJournal TitlePublished Year
35552610Phosphorylated α-synuclein in skin Schwann cells: a new biomarker for multiple system atrophy.Brain2023
34520581Midbrain area and the hummingbird sign from brain MRI in progressive supranuclear palsy and idiopathic normal pressure hydrocephalus.J Neuroimaging2022
35679097Toward Improved Treatment and Empowerment of Individuals With Parkinson Disease: Design and Evaluation of an Internet of Things System.JMIR Form Res2022
35705502Pharmacokinetics of Intravenously (DIZ101), Subcutaneously (DIZ102), and Intestinally (LCIG) Infused Levodopa in Advanced Parkinson Disease.Neurology2022
35785401Levodopa-entacapone-carbidopa intestinal gel infusion in advanced Parkinson's disease: real-world experience and practical guidance.Ther Adv Neurol Disord2022
36550460Attitudes and values among the Swedish general public to using human embryonic stem cells for medical treatment.BMC Med Ethics2022
36449420Trial of Deferiprone in Parkinson's Disease.N Engl J Med2022
36261826Patients' views on using human embryonic stem cells to treat Parkinson's disease: an interview study.BMC Med Ethics2022
35207734Optimizing Treatment of Parkinson's Disease.J Pers Med2022
35339864Composite attenuation correction method using a <sup>68</sup>Ge-transmission multi-atlas for quantitative brain PET/MR.Phys Med2022
35164790Higher levels of neurofilament light chain and total tau in CSF are associated with negative outcome after shunt surgery in patients with normal pressure hydrocephalus.Fluids Barriers CNS2022
33164946Effects of Helicobacter pylori on Levodopa Pharmacokinetics.J Parkinsons Dis2021
33807308Initial Experience of the Levodopa-Entacapone-Carbidopa Intestinal Gel in Clinical Practice.J Pers Med2021
34442364Personalized Medicine Approach in Treating Parkinson's Disease, Using Oral Administration of Levodopa/Carbidopa Microtablets in Clinical Practice.J Pers Med2021
34641829Pain, disease severity and associations with individual quality of life in patients with motor neuron diseases.BMC Palliat Care2021
34689840An updated calculator for determining levodopa-equivalent dose.Neurol Res Pract2021
34325703Imaging features associated with idiopathic normal pressure hydrocephalus have high specificity even when comparing with vascular dementia and atypical parkinsonism.Fluids Barriers CNS2021
33949144Close relationships in Parkinson´s disease patients with device-aided therapy.Brain Behav2021
33247616Proenkephalin Decreases in Cerebrospinal Fluid with Symptom Progression of Huntington's Disease.Mov Disord2021
30763248Motion Sensor-Based Assessment of Parkinson's Disease Motor Symptoms During Leg Agility Tests: Results From Levodopa Challenge.IEEE J Biomed Health Inform2020
31982667A multiple motion sensors index for motor state quantification in Parkinson's disease.Comput Methods Programs Biomed2020
31766928Everyday Occupations and Other Factors in Relation to Mental Well-Being among Persons with Advanced Parkinson's Disease.Occup Ther Health Care2020
33369700Accuracy and precision of zero-echo-time, single- and multi-atlas attenuation correction for dynamic [<sup>11</sup>C]PE2I PET-MR brain imaging.EJNMMI Phys2020
33025722A survey of lifestyle factors in dystonia.Brain Behav2020
33093598Population pharmacokinetics of levodopa gel infusion in Parkinson's disease: effects of entacapone infusion and genetic polymorphism.Sci Rep2020
32651335Real-Life Use of Levodopa/Carbidopa Intestinal Gel in Parkinson's Disease According to Analysis of Pump Data.J Parkinsons Dis2020
32154902[Parkinson's disease - heterogeneous and complex in its clinical presentation].Lakartidningen2020
32198802A Phase 2a Trial Investigating the Safety and Tolerability of the Novel Cortical Enhancer IRL752 in Parkinson's Disease Dementia.Mov Disord2020
30659356Sensor-based algorithmic dosing suggestions for oral administration of levodopa/carbidopa microtablets for Parkinson's disease: a first experience.J Neurol2019
30180267The effect of continuous levodopa treatment during the afternoon hours.Acta Neurol Scand2019
30858393Alterations in the tyrosine and phenylalanine pathways revealed by biochemical profiling in cerebrospinal fluid of Huntington's disease subjects.Sci Rep2019
30935826Evaluation of a sensor algorithm for motor state rating in Parkinson's disease.Parkinsonism Relat Disord2019
29278279A randomized, double-blind, placebo-controlled trial of camicinal in Parkinson's disease.Mov Disord2018
29989996A Treatment-Response Index From Wearable Sensors for Quantifying Parkinson's Disease Motor States.IEEE J Biomed Health Inform2018
29882153Population pharmacokinetics of levodopa/carbidopa microtablets in healthy subjects and Parkinson's disease patients.Eur J Clin Pharmacol2018
30345471Evaluation of zero-echo-time attenuation correction for integrated PET/MR brain imaging-comparison to head atlas and <sup>68</sup>Ge-transmission-based attenuation correction.EJNMMI Phys2018
30534585Safety and tolerability of IRL790 in Parkinson's disease with levodopa-induced dyskinesia-a phase 1b trial.NPJ Parkinsons Dis2018
29500011Individual dose-response models for levodopa infusion dose optimization.Int J Med Inform2018
29569237Workforce participation and activities in Parkinson's disease patients receiving device-aided therapy.Acta Neurol Scand2018
29652438Individualization of levodopa treatment using a microtablet dispenser and ambulatory accelerometry.CNS Neurosci Ther2018
27987231Levodopa-entacapone-carbidopa intestinal gel in Parkinson's disease: A randomized crossover study.Mov Disord2017
28416144Feasibility of spirography features for objective assessment of motor function in Parkinson's disease.Artif Intell Med2017
28276779Development of new levodopa treatment strategies in Parkinson's disease-from bedside to bench to bedside.Ups J Med Sci2017
28299787First clinical experience with levodopa/carbidopa microtablets in Parkinson's disease.Acta Neurol Scand2017
28101657Levodopa/carbidopa microtablets in Parkinson's disease: a study of pharmacokinetics and blinded motor assessment.Eur J Clin Pharmacol2017
28344656Levodopa-carbidopa enteral suspension in advanced Parkinson's disease: clinical evidence and experience.Ther Adv Neurol Disord2017
29059827Using measurements from wearable sensors for automatic scoring of Parkinson's disease motor states: Results from 7 patients.Annu Int Conf IEEE Eng Med Biol Soc2017
28984615Initiation of Levodopa-Carbidopa Intestinal Gel Infusion Using Telemedicine (Video Communication System) Facilitates Efficient and Well-Accepted Home Titration in Patients with Advanced Parkinson's Disease.J Parkinsons Dis2017
29027941Verification of a Method for Measuring Parkinson's Disease Related Temporal Irregularity in Spiral Drawings.Sensors (Basel)2017
29348981Development of a clinically feasible [<sup>11</sup>C]PE2I PET method for differential diagnosis of parkinsonism using reduced scan duration and automated reference region extraction.Am J Nucl Med Mol Imaging2017
  • 1 - 50 of 108

Recommended Authors

Jessika Suescun
McGovern Medical School, University of Texas Health Science Center at Houston
Career Start Year 2013
Number of shared co-authors 0
Roger A Barker
University of Cambridge
Career Start Year 2013
Number of shared co-authors 0
Kalea Colletta
Hines Veterans Affairs Hospital
Career Start Year 2011
Number of shared co-authors 0
Amy W Amara
University of Colorado
Career Start Year 2011
Number of shared co-authors 0
Jose-Alberto Palma
New York University School of Medicine
Career Start Year 2009
Number of shared co-authors 0
Rita Khoury
Saint Louis University
Career Start Year 2009
Number of shared co-authors 0
Michelle Rainka
From the Dent Neurologic Institute
Career Start Year 2008
Number of shared co-authors 0
Jordan J Elm
Medical University of South Carolina
Career Start Year 2002
Number of shared co-authors 0
Jennifer S Hui
Keck School of Medicine of USC
Career Start Year 2001
Number of shared co-authors 0
Victor W Sung
University of Alabama at Birmingham
Career Start Year 1998
Number of shared co-authors 0
Hubert H Fernandez
Center for Neurological Restoration, Neurological Institute, Cleveland Clinic
Career Start Year 1998
Number of shared co-authors 0
Fenna T Phibbs
Vanderbilt University Medical Center
Career Start Year 1998
Number of shared co-authors 0
Karen E Anderson
Georgetown University
Career Start Year 1996
Number of shared co-authors 0
Giselle M Petzinger
Keck School of Medicine, University of Southern California
Career Start Year 1995
Number of shared co-authors 1
Samuel M Goldman
University of California-San Francisco
Career Start Year 1994
Number of shared co-authors 0
Richard Bedlack
Duke University
Career Start Year 1992
Number of shared co-authors 0
Zoltan Mari
Lou Ruvo Center for Brain Health, Cleveland Clinic Nevada
Career Start Year 1991
Number of shared co-authors 0
Huw R Morris
Queen Square Institute of Neurology, University College London
Career Start Year 1991
Number of shared co-authors 2
Tatsuya Yamamoto
Gladstone Institutes
Career Start Year 1987
Number of shared co-authors 0
Martin R Farlow
Stark Neurosciences Research Institute, Indiana University School of Medicine (IUSM)
Career Start Year 1986
Number of shared co-authors 1
Roger A Barker
John Van Geest Center for Brain Repair, University of Cambridge
Career Start Year 1986
Number of shared co-authors 2
Lon S Schneider
Keck School of Medicine (EJ, University of Southern California
Career Start Year 1983
Number of shared co-authors 1
Pierre N Tariot
Banner Alzheimer's Institute
Career Start Year 1983
Number of shared co-authors 0
Mya C Schiess
McGovern Medical School at UTHealth
Career Start Year 1982
Number of shared co-authors 0
Caroline M Tanner
UCSF School of Medicine and San Francisco VA Health Care System
Career Start Year 1980
Number of shared co-authors 1
Thomas L Davis
Vanderbilt University Medical Center
Career Start Year 1979
Number of shared co-authors 0
David G Standaert
University of Alabama at Birmingham
Career Start Year 1977
Number of shared co-authors 1
Joseph J Locascio
Harvard Medical School, Massachusetts General Hospital
Career Start Year 1975
Number of shared co-authors 0
Carl H Sadowsky
Premier Research Institute and NOVA SE University
Career Start Year 1975
Number of shared co-authors 0
Mahlon R DeLong
Emory University School of Medicine
Career Start Year 1965
Number of shared co-authors 1

Collaborators

Anders Johansson
Dept of Clinical Neurosciences, Karolinska Institutet
Co-authored papers 19
Nil Dizdar
Department of Biomedical and Clinical Sciences, Linkoping University
Co-authored papers 8
H??kan Widner
Skane University Hospital
Co-authored papers 7
Sven P??lhagen
Department of Neurology Karolinska University Hospital Huddinge Stockholm Sweden.
Co-authored papers 5
Rasmus Jansson-L??fmark
Unit for Pharmacokinetics and Drug Metabolism, University of Gothenburg
Co-authored papers 4
Bj??rn Holmberg
Sahlgrenska University Hospital
Co-authored papers 4
Olof Sydow
Karolinska Institutet
Co-authored papers 3
Jan Linder
Division of Clinical Neuroscience, Umea University
Co-authored papers 3
Tove Hauge
Molde Hospital HNR
Co-authored papers 2
Mats G Hansson
Centre for Research Ethics & Bioethics, Uppsala University
Co-authored papers 1
Martin Ingelsson
Co-authored papers 1
M Wainwright
Seattle Children's Hospital, University of Washington
Co-authored papers 1
David J Burn
Population Health Sciences Institute, Newcastle University
Co-authored papers 1
Rachel A Gibson
Guy's Hospital
Co-authored papers 1
Ola Spjuth
Department of Pharmaceutical Biosciences, Uppsala University
Co-authored papers 1
Release 1.2